Phase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States

por Wang-Gillam, Andrea, Schelman, William, Ukrainskyj, Stacey, Chien, Caly, Gonzalez, Martha, Yang, Zhao, Kania, Marek, Yeckes-Rodin, Heather
Publicado 2023